- Home
- HAPN vs HCM Comparison
HAPN vs HCM Comparison
Compare HAPN & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$11.01
Company Overview
Basic Information| Metric | HAPN | HCM |
|---|---|---|
| Founded | N/A | 2000 |
| Country | United States | Hong Kong |
| Employees | N/A | 1796 |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HAPN | HCM |
|---|---|---|
| Price | $18.06 | $11.01 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.75 |
| AVG Volume (30 Days) | ★ 1.6M | 50.9K |
| Earning Date | N/A | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $20.60 |
| Revenue Next Year | N/A | $15.62 |
| P/E Ratio | ★ N/A | $5.49 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.93 | $9.77 |
| 52 Week High | $21.21 | $19.50 |
Technical Indicators
Market Signals| Indicator | HAPN | HCM |
|---|---|---|
| Relative Strength Index (RSI) | 33.38 | 47.58 |
| Support Level | N/A | $10.83 |
| Resistance Level | $20.94 | $11.80 |
| Average True Range (ATR) | 0.68 | 0.23 |
| MACD | -0.17 | 0.01 |
| Stochastic Oscillator | 6.22 | 16.67 |
Price Performance
Historical Comparison HAPN
HCM
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.